Why MasterCard Inc (NYSE: MA) Stock is a Buy

396 0 0 0 0 0 (0)

MasterCard Inc (NYSE: MA) is something that most of us have in our wallet or purse and use frequently. MA belongs to the Financial Transaction Services industry, a group that includes 25 individual companies. However, there are about 35,000 such U.S. companies but the 50 largest companies hold more than 80% of the market. It is a very competitive space. However, MA has returned about 37.58% since the start of the calendar year.

In comparison, Business Services companies have returned an average of 12.42%. Mastercard (NYSE:MA) is performing better than its sector and will likely be looking to continue its solid performance, so investors interested in Business Services stocks should continue to pay close attention to the company. For those looking to find strong Business Services stocks, we think MA Stock is the one to Buy. 

The holy grail of investing is to find the biggest winning stocks in the market. The outliers. The stocks that break all of the records ... i.e., the leaders that go up the most and that is what we do on the HadePlatform.  Over the past week, MasterCard Inc (NYSE: MA) investment grade on the Hade Platform has risen steadily, making it a Top 30 stock. Ironically, this stability in overall rating happens during a time when the overall market is falling, and as our investment grades as an average have consistently declined for the last four months, effectively predicting a correction.

With overall investment grades still lower, we suggest holding large sums of cash and being very selective when making investment decisions. According to MA stock’s current grade, it might very well be one of those selective opportunities. Why should you trust our ratings? The Hade Platform has proven over the course of three years through the application of DLAs and artificial intelligence that it consistently outperforms Wall Street consensus estimates (63%) and major benchmarks such as the S&P 500 (250%). Access our premium services and start beating the market.

Free users on Hade Platform can build a watchlist of stocks and access investment grades from our database of more than 4,000 securities. Premium members can access the platform to get an instant look at which stocks rate highest for value, growth, dividend, and which have the greatest short-term momentum, thereby allowing members to identify areas of opportunity. Premium services include interest trends, risk analysis, machine learning predictions, Top 100 stocks, MatriX Portfolio and more.

Comments (0)

Recent Updates

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Healthcare Total Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Helathcare Other of which Gold Bond Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Polio/Pertussis/Hib Vaccines (incl. Hexaxim/Hexyon, Pentacel, Pentaxim and Imovax) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Influenza Vaccines (incl. Vaxigrip, Fluzone HD, Fluzone, Flublok) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Meningitis/Pneumo Vaccines (incl. Menactra) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Adult Booster Vaccines (incl. Adacel) Revenue